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Abstract 
Objective: to survey how outcomes in recent Cochrane Reviews were defined and used for inclusion 
of studies and how this compares with guidance on preventing outcome reporting bias. 
Study Design and Setting: A survey of Cochrane reviews. We extracted data on the outcomes and 
how the outcomes were used for inclusion of studies in the review.  
Results: We included 52 reviews with a mean of 8.4 (SD 4.3) outcomes. Of all reviews 47 (90%) used 
primary and secondary outcomes as the names for their review’s outcomes, but without further 
definition. None reported using a core outcome set. Forty reviews (77%) did not explain if they used 
outcomes for inclusion of studies, 8 (15%) stated that studies were included if they reported either 
primary or secondary outcomes, 1 (2%) reported that outcomes were not used for inclusion and for 
3 (6%) this was unclear.  
Conclusions: In a sample of Cochrane Reviews, most reviews did not state if outcomes were used for 
inclusion of studies. Better explanation of inclusion decisions is needed to be able to understand the 
risk of outcome reporting bias in a review. Consistent guidance in names and definitions for different 
types of outcomes used in systematic reviews is needed. 
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What is new? 
Key findings 
- 77% (N=52) of a sample of recent Cochrane Systematic Reviews did not state if and how 
they used the reporting of outcomes for inclusion of studies 
- More than half of the sample used more than 7 primary outcomes contrary to the 
guidance 
 
What this adds to what is known 
- Outcome reporting bias is known to occur in Cochrane reviews. Not knowing how studies 
were included increases the risk of outcome reporting bias 
 
What is the implication, what should change now? 
- Cochrane reviews should better report reasons for including studies that relate to study 
outcomes 
Introduction 
The four PICO elements, patients (P), intervention (I), comparator (C) and outcomes (O), together 
with the type of study design (S), determine the main structure of a systematic review.[1, 2] For 
decades, the PICO elements have proven an important instrument to determine which exact 
question is answered by the review because the four elements are used as criteria to include or 
exclude studies in a review.[3, 4] Recently, the use of outcomes as inclusion criteria has become 
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more under scrutiny because of the possibility of outcome reporting bias, which would distort the 
conclusions of a systematic review.[5]   
The term outcome itself is ambiguous and can refer to the outcome of the disease process, the 
effect of an intervention or the quality of a health service.[6, 7] Because different context can lead to 
different meanings, here, we refer to an outcome as an effect of intervention in the context of 
Cochrane reviews and not as the outcome as part of the assessment of quality of care. The 
outcomes in reviews are used to answer the question if an intervention works. 
Outcome reporting bias has been defined as a bias that can arise when a trial is excluded from a 
systematic review or meta-analysis completely, for example, because the results are only reported 
as “not significant”.[5] Because the outcomes that are not reported are likely to show non-significant 
effects, a review that excludes these studies would show a too beneficial result. This type of bias 
should be prevented by contacting authors of the included study and ask them to provide the 
missing data. If these can’t be obtained, the impact of the missing data should be assessed in a 
sensitivity analysis.[8] Another, more preventive, solution to this problem is the standardization of 
outcomes for specific conditions as advocated by the COMET initiative (Core Outcome Measures in 
Effectiveness Trials). These outcomes should be used and reported in all trials and systematic 
reviews.[9] However, repeated surveys of Cochrane Reviews between 2007 and 2013 reported that 
core outcome sets were not used in the reviews.[10, 11] These surveys also found that more than 
30% of the Cochrane reviews did not report all pre-specified outcomes, which increases the risk of 
outcome reporting bias. 
Bias can also arise from the way a systematic review uses primary and secondary outcomes for the 
inclusion of studies. Figure 1 shows the three possible strategies that may underlie inclusion of 
studies in reviews. When not explicitly reported in the review methods, it is difficult to judge the risk 
of outcome reporting bias.  In general, not using the primary or secondary outcomes as an inclusion 
criterion (Figure 1, scenario A) is preferred to prevent outcome reporting bias. Sometimes, only the 
primary outcomes are used for inclusion of studies in a systematic review (Figure 1, scenario C). This 
means that studies that only report the secondary outcomes will not be included. The included 
studies that do report the secondary outcome are then only a subset of all available studies that 
reported these secondary outcomes. As long as the review does not use the secondary outcomes for 
drawing conclusions on the effectiveness of the intervention, this does not cause new problems. 
However, the possibility of outcome reporting bias arises when the secondary outcomes are used for 
the conclusions. Therefore, when authors use primary and secondary outcomes, they should make 
clear how these have been used for the inclusion of studies and conclusions of the effectiveness of 
the intervention. In addition, consideration needs to be given to those studies reporting only the 
secondary outcomes, to assess whether the primary outcome may have been measured but not 
reported for reasons related to the results, thus inducing outcome reporting bias that would affect 
the interpretation of the results for the primary outcome. 
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There is detailed information available on how to do a systematic review. The Cochrane Handbook, 
the PRISMA reporting guideline and the GRADE guidelines are the most authoritative resources.[12-
14] However, the information on handling of outcomes, although extensive, still has some gaps and 
overlaps that lead to varied practice based on interpretation or preference. This holds especially for 
the number and type of outcomes used as criteria for inclusion of studies in a systematic review and 
its’ effect on conclusions of a review which has not been studied before. 
Objective 
Our objective is to find out how outcomes in recent Cochrane Reviews were defined and used for 
inclusion of studies and how current practice compares with existing guidance. 
Methods 
Assessment of current practice of Cochrane reviews 
We located the last review as of August 2016 from each Cochrane Review Group. From the method 
section and the Summary of Findings (SoF) tables in each review we assessed 
- Type of review as being related to treatment directed at curing patients, related to 
prevention directed at healthy participants, related to both objectives, or related to studying 
the side-effects (such as pain) of therapeutic or diagnostic procedures; 
- Naming of outcomes as provided by the authors; 
- Number of primary and secondary outcomes listed in the methods section; 
- Type of participants defined either by a specific medical condition (e.g. diabetic) or as 
healthy persons ; 
- If the outcome of review was not related to the medical condition or disease as defined by 
the type of participants (diabetes status/ HbA1C); In most reviews the participants have a 
disease and the same disease is the outcome of interest. In that case we noted that there 
was no difference between the participants and the outcome. Otherwise we noted there 
was a difference. 
- Inferred reason for difference between outcome and participants such as the intervention 
being preventive or a procedure; The inferred reason for a difference was a preventive 
intervention when patients were healthy and the outcome was a specific disease outcome 
for example coronary artery disease. The reason was that the intervention was related to a 
Figure 1: Study inclusion using different criteria for outcomes. A: Inclusion regardless of outcome reported, 
primary outcomes in yellow circle (pO), secondary outcomes in green circle (sO). B: Inclusion of studies that 
report either primary outcomes (pO, yellow circle) or secondary outcomes (sO, green circle). C: Inclusion of 
only studies that report the primary outcome. P (red circle): participants, I (blue circle): Intervention. The 
grey area represents the included studies 
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procedure when the patients had a disease or various diseases for which a procedure was 
needed and the outcome was a result of the procedure for example catheter insertion and 
pain.  
- Any statement in methods for use of  primary and/or secondary outcomes for inclusion; 
- If the authors elaborated how they used outcomes for inclusion and reporting; 
- If the authors elaborated inclusion of the outcomes in SoF tables; 
- If the authors used search terms for participants, the intervention and/or the outcome; 
- How many primary and secondary outcomes were used in the SoF tables; 
- Which (primary or secondary or both) outcomes were reported in the abstract as an 
indication of contributing to the main conclusions of the review. 
One reviewer (JV) extracted these data from the reviews into an Excel sheet. The other two authors 
(SI, CT) checked the data for accuracy. Disagreements were discussed amongst all three until 
consensus was reached. 
Descriptive statistics (frequencies and mean (SD)) were calculated for the extracted data in Excel. 
We compared how well the sample of reviews complied with guidance on systematic reviews from 
four documents: . the Cochrane Handbook of reviews of effectiveness of interventions, the 
Methodological Expectations of Cochrane Intervention Reviews (MECIR) , the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA), and the guidance produced by the 
working group on Grading of Recommendations Assessment, Development and Evaluation 
(GRADE).[12-15] We collated the relevant information for the outcome related criteria for inclusion 
of studies, the naming for different types of outcomes, and the number of outcomes advised. Our 
findings are detailed below. 
The Cochrane Handbook 
In paragraph 5.1.2 and 5.4, the Cochrane handbook advises to take the three elements, Participants, 
Interventions, and Outcomes together with the type of study design as the criteria for inclusion of 
studies in a review. However, it simultaneously recommends not using the outcomes for searching 
of studies in the review. The reason for this is to “seek all rigorous studies…irrespective of the 
outcomes measured or reported” or in other words to avoid outcome reporting bias. This approach 
works when the review question at hand is defined by the participants and/or the intervention 
which is the case for most treatments for most patients. For example in a review of specific 
chemotherapy for breast cancer, the intervention and the participants would be sufficiently specific 
to include and locate all relevant studies. This approach avoids having to list all possible outcomes 
that studies could report for breast cancer.  
At the same time, the handbook acknowledges in paragraph 5.1.2 that in some cases outcomes have 
to be used as an inclusion criterion because the participants and the intervention are not specific 
enough to locate studies. This is the case when the intervention can be studied for other purposes 
than the disease of interest: when adverse or unusual effects are addressed or when the 
intervention is preventive. For example, a review on the adverse effects of non-steroidal anti-
inflammatory drugs that are used for back pain, omitting the adverse outcomes from search and 
selection would result in effectiveness related studies: the adverse outcomes would be needed to 
include the right studies and locate them. However, it has been pointed out that also in these cases 
there is a serious risk of outcome reporting bias that should be taken into account.[16]  If the focus 
of interest is if a specific medical procedure can reduce pain in a specific patient group, pain as an 
outcome is needed as an inclusion criterion because the definition of the participants does not 
include pain. If the focus of the review is on aspirin for preventing cardiovascular outcomes in 
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healthy persons, cardiovascular outcomes have to be used as a criterion to include and locate 
relevant studies because aspirin may be used for many conditions. In these cases the participants 
and the intervention together are still not specific enough to include and locate studies.    
The handbook continues with the advice to include all outcomes that are meaningful to practitioners 
and decision makers. It further suggests to use core outcome sets when these are available and to 
harmonize outcomes across Cochrane reviews for the ease of making ‘overviews’ of multiple 
systematic reviews.  
Finally, the handbook divides the review outcomes in three non-exclusive categories: main, primary 
and secondary outcomes. Main outcomes are the essential outcomes for decision-making, and those 
should always be in the ‘Summary of findings’ (SoF) table. These should be restricted to seven 
outcomes at most and should not ‘generally’ include surrogate or interim outcomes. Primary 
outcomes are those among the main outcomes that are expected to be analyzed should the review 
identify relevant studies. Also, the conclusions about the effects of the interventions under review 
will be largely based on these outcomes. These should be limited to three and include at least one 
desirable (benefit) and one undesirable (harm) outcome. Secondary outcomes are the remaining 
main outcomes other than primary outcomes plus any additional outcomes useful for explaining 
effects. However, the handbook does not give guidance on how to use the primary, secondary or 
main outcomes for inclusion of studies in an effectiveness review. 
MECIR  
The MECIR criteria that have been developed based on the handbook and that are used to assure 
the quality of Cochrane reviews, formulate the guidance on inclusion in different wording but with a 
similar meaning.[12] MECIR advises that studies should never be excluded from a review solely 
because no outcomes of interest were reported. This means outcome should not be used as an 
inclusion criterion alongside participants and intervention. However, they admit that on occasion it 
will be appropriate to include only studies that measured particular outcomes (for example a 
multicomponent public health intervention for smoking reduction can exclude studies that don’t 
report smoking rates). The MECIR conduct standard specifies that authors should clarify in advance 
whether outcomes listed under 'Criteria for considering studies for this review' are used as criteria 
for including studies (rather than as a list of the outcomes of interest within whichever studies are 
included).  
PRISMA reporting guideline 
In the PRISMA reporting guideline, there is no clear definition of main, primary or secondary 
outcomes.[14] The authors interchangeably used ‘most important’, ‘of primary interest’, or ‘main 
outcome’ to describe of the same concept. They do use the terms ‘primary’ and ‘secondary’ 
outcomes in their examples, where adverse effects are listed as secondary outcomes. They ask 
authors to clearly specify eligibility criteria used in the review: “study eligibility criteria are likely to 
include the population, the intervention, the comparator, the outcome, and the study designs of 
interest, as well as other study specific elements, such as specifying a minimum length of follow-up. 
Authors should state whether studies will be excluded because they do not include (or report) 
specific outcomes to help readers ascertain whether the systematic review may be biased as a 
consequence of selective reporting.” 
GRADE guidance 
 7 
 
The GRADE working group advises to include a maximum of seven outcomes in the SoF table of a 
systematic review. [17] The group considered this the most amount of information that a reader can 
grasp. For the development of guidelines, GRADE advises to list up to nine outcomes and divide 
these into ‘critical’ and ‘non-critical’ outcomes.[13]  Guideline developers usually consider a number 
of interventions at the same time and therefore need a number of systematic reviews on the same 
condition. This makes the approach to the naming and number of outcomes different. 
Results  
Characteristics of included reviews 
We included 52 reviews of which each was the most recently published review from a Cochrane 
review group (Table 1).  
Item surveyed Categories Survey 
findings 
% (n); mean ± 
SD 
Type of interventions in Review 
 Treatment  75 % (39) 
 Prevention  19 % (10) 
 Treatment and prevention  2 % (1) 
 Procedures (diagnostic or therapeutic) 4 % (2) 
Naming of outcomes  
 Primary and Secondary  90 % (47) 
 Main and Secondary  2 % (1) 
 Major and Minor 2 % (1) 
 Outcomes of interest 2 % (1) 
 Primary, secondary and adverse  2 % (1) 
 No name  2 % (1) 
Number of outcomes in methods section of review                                                                                                      
 Total outcomes per review  8.4 ± 4.3 
  Range 2 to 25 
 Reviews with more than 7 outcomes  54 % (28) 
 Primary outcomes per review 2.5 ± 1.5 
 Reviews with more than 3 primary outcomes  19 % (10) 
 Secondary outcomes per review  5.8 ± 4.1  
 Reviews with more than 4 secondary outcomes 56 % (23) 
Number of outcomes in Summary of Findings (SoF) tables 
 Total SoF outcomes per review 4.4 ± 2.2 
  Range 1 to 8 
 Reviews with more than 7 outcomes in SoF  9 % (4) 
 Primary outcomes in SoF per review 2.2 ± 1.5 
 Reviews with more than 3 primary outcomes in SoF 28 % (13) 
 Secondary outcomes in SoF per review 2.3 ± 1.9  
 Reviews with more than 4 secondary outcomes in SoF  13 % (6) 
 
Table 1. Characteristics of Cochrane reviews (N=52) included in the survey in terms of nomenclature 
and numbers of their included outcomes; m ± sd = mean ± standard deviation 
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Most reviews evaluated effectiveness of interventions directly aiming to reduce the consequences of 
the disease while 25% evaluated either preventive interventions such as caries prevention [18] or 
evaluated  the side effects of treatment or  medical procedures [19].  
The naming of the outcomes used in the reviews was almost always based on the default headings in 
the RevMan program used for producing Cochrane Reviews: primary and secondary outcomes. 
Except in two cases where the authors had changed this to major and minor outcomes and to main 
and secondary outcomes but there was no explanation in the review why this had been changed.[20, 
21] In one other review there was no name and again in another review the outcomes were just 
named “outcomes of interest”.  
Most reviews listed more than seven outcomes but kept the number of primary outcomes to three 
or fewer. The number of outcomes in the Summary of Findings tables was more in line with the 
guidance with an average of four. 
Sometimes, the review authors did not clearly state the relationship between outcome concepts and 
outcome measures. For example pain is an outcome concept and the various instruments or scales 
to measure pain are outcome measures. In one review, the authors listed and reported the various 
pain measures all as different outcomes without an elaboration of the reasons for this, which led to 
a large number of SoF tables.[22]  
Outcomes as criteria to include or exclude studies 
The majority of the reviews (77 %) did not specify if or how they used outcomes in their methods 
section.  The methods section of a Cochrane Review contains the heading: ’Criteria for considering 
studies for this review’. Under this heading there are Study designs, Participants, Interventions and 
Outcomes as the criteria. In most cases, there were only criteria under these headings and no 
elaboration of why these were chosen or how they were used. It is possible that studies were 
included whenever these reported any of the primary or secondary outcomes but it is also possible 
that they were only included when they reported one of the primary outcomes (Table 2, Figure 1). A 
small proportion of the reviews (15 %) explained that they included studies if a study reported any of 
the primary or the secondary outcomes which is scenario B in figure 1. One review stated that the 
outcomes were not used for inclusion of studies at all which is scenario A in figure 1.[23]  As a 
consequence they included several studies but could not use the included studies for drawing 
conclusions because the studies did not report the outcome of interest. Another review detailed the 
inclusion criteria in an appendix but it was difficult to follow how this had led to inclusion of studies 
and we categorized this as unclear.[24]  
Item surveyed Categories Survey findings 
% (N) 
Inclusion criteria explanation 
 Outcome not used for inclusion (A) 2 % (1) 
 Inclusion based on either primary or secondary outcome 
in study (B) 
 
15 % (8) 
 Explanation unclear 6 % (3) 
 No explanation 77 % (40) 
Primary outcome not specified by definition of participants 
 Reviews with different Outcomes and Participants 29 % (15) 
                                       Reasons why outcome different from participants  
 Preventive intervention 15 % (8) 
 Procedures evaluated 10 % (5) 
 9 
 
 Only adverse effects evaluated 2 % (1) 
 Treatment unrelated to disease 2 % (1) 
PICO elements used for search 
 Search did not include Outcome 70 % 
 Search did include Outcome 30 % 
Secondary outcomes in conclusions 
 Not in Summary of Findings 17 % (8) 
 Not in Abstract 17 % (8) 
Table 2. Explanation of inclusion criteria for outcomes in the included Cochrane Systematic Reviews 
(n=52). A and B refers to the diagrams in figure 1. 
 
Difference between Participants and Outcomes 
In a substantial proportion of the reviews (29 %), the definition of the participants was not sufficient 
to specify the outcome. (Table 2) For example, in a population catheterized long term for urinary 
tract conditions, the primary outcome was patient satisfaction.[25] Another reason for difference 
was that the intervention did not directly target the disease of the patients such as interventions to 
prevent sudden death in patients with epilepsy [26] or where the intervention consisted of a 
procedure and the outcomes were related to the procedure and not to the disease of interest. The 
third situation was where participants were healthy persons targeted for primary prevention.  
In a third of reviews surveyed (30%), the outcomes were used in the search. Still, 20% of the reviews 
that contained outcomes that were defined by the disease of the participants used the outcomes in 
the search. Reviews that included outcomes that were not defined by the disease of the participants 
used the outcomes in 53% of the cases in their searches. 
Use of secondary outcomes in SoF and abstract 
In a majority (83%) of the reviews, secondary outcomes, not specified as important for decision 
making, were reported in the SoF tables or the abstract of the review where the guidance does not 
recommend this. 
Discussion 
In the sample of recent Cochrane systematic reviews, 77% of the reviews did not specify if and how 
the outcomes had been used for inclusion of studies in contrast to guidance. In the other 23% 
practice ranged from outcomes not being used for inclusion at all, to using both the primary and the 
secondary outcomes for inclusion or a detailed list of outcomes used for inclusion. Most reviews had 
more than seven outcomes in the methods section but did comply with guidance to include no more 
than seven main outcomes in their SoF tables. 
Strengths 
A strength of our study is that we took a census of all the Cochrane groups’ latest reviews accounting 
for variation across Cochrane Review Groups in terms of types of reviews, types of participants, 
interventions, outcomes, and methods used. In addition, we systematically extracted data and 
appraised the elaboration of inclusion criteria in duplicate achieving consensus, increasing the 
validity of the data. We also looked at aspects of the reviews that are important for the inclusion of 
studies such as the type of intervention being evaluated being treatment, preventive or procedure 
associated. With 52 cases included, the confidence interval for 100% of the reviews not giving an 
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explanation would range from 94% to 100% which is sufficiently narrow to be able to draw 
conclusions. 
Limitations 
We included only one review per Cochrane group and therefore we do not claim this to be 
representative of a group’s reviews or policies. We assumed that there will be more variation 
between groups than within groups because most groups have an established approach of their own 
in conducting systematic reviews. Taking a sample across groups ensured that this source of 
variation was taken into account. Some of the issues that we considered, such as the type of review, 
being preventive or treatment, were based on our interpretation of the data. However, all three 
authors are experienced systematic reviewers and all data were checked in duplicate and agreed 
upon which should limit interpretation biases. 
Interpretation of the findings 
Although the headings in Cochrane reviews clearly state that the four elements Study design, 
Participants, Interventions and Outcomes have been used for inclusion, our survey shows that it is 
unclear if this the case. The MECIR criteria prescribe that there should be an explanation of the 
inclusion of studies but in most reviews an explanation is missing. This means that the readers of 
Cochrane reviews cannot always know how the process of including studies has gone based on the 
information reported in the methods section of the review. 
Unclear use of main, and primary and secondary outcomes for inclusion can possibly lead to 
outcome reporting bias. We don’t know of any studies that have compared the effects on secondary 
outcomes between reviews that included studies based on reporting of primary outcomes only and 
those that included studies based on reporting either primary or secondary outcomes. After all, if 
the secondary outcomes are considered minor and less important outcomes that don’t play a major 
role in the analysis, we could imagine that the subset of studies that have reported both the primary 
and the secondary outcomes are of better quality than those that only report the secondary 
outcomes. Therefore, it might not be problematic in terms of outcome reporting bias to use only 
those studies that report the primary outcome as long as the authors take into account the risk of 
outcome reporting bias for both the primary and the secondary outcomes. 
Inclusion of studies that don’t measure and report the outcome of interest at all to prevent outcome 
reporting bias makes it difficult to draw conclusions about outcome reporting bias or otherwise. To 
readers of the reviews that included studies regardless of outcome reporting, it can be very 
confusing that studies were included but still no conclusions could be drawn. The ORBIT approach to 
reduce the risk of outcome reporting bias only allows the exclusion of such studies if there is a 
statement in the article that the outcome was not measured.[5] However, other guidance 
documents like MECIR and the Cochrane Handbook leave room for excluding studies based on 
outcomes in specific situations.[12, 15] 
Inclusion of studies that report any of the primary or secondary outcomes makes interpretation of 
findings also more difficult. There are numerous reviews that include a great number of studies that 
report the secondary outcome only. To readers of these reviews, it can be a disappointing 
experience to be offered the effects on a different outcome that was not of main interest. For 
example, a review on double gloving to reduce wound infection in surgical patients found two 
studies that reported on the primary outcome, wound infection, but 31 studies that reported on 
glove perforations, considered a secondary outcome.[27] The conclusions about the effects on the 
primary outcome were inconclusive but double gloving clearly prevented perforations in the inner 
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gloves. However, the relation between glove perforations and wound infections is unknown and 
therefore these results could not be used for drawing conclusions. In our view, it is clearer if the 
secondary outcomes are only used to support the findings of the primary outcomes. If both wound 
infection and holes in gloves decreased, this would make a stronger case for the effectiveness of the 
intervention.  
If reviewers want to use primary and secondary outcomes in a review using the primary outcomes 
for inclusion of studies and using the available secondary outcomes for explanation, they should 
then acknowledge that, for the secondary outcomes, the studies form only a subset of all studies 
that have measured the secondary outcomes. (Scenario C in Figure 1) To avoid confusion with the 
use of primary and secondary outcomes in trials, a name change could be considered. We propose 
main outcomes for those outcomes that will lead to conclusions about the effectiveness of the 
intervention as per current Cochrane handbook guidance and explanatory outcomes for those that 
can support this but would not be sufficient evidence on their own. A logic model can help to explain 
how the intervention will lead to the outcome, which outcomes are important and which would be 
explanatory.[28] It would also be helpful to use the ORBIT approach and report a table that shows 
which studies used which outcome/measurements.[8] (see http://ctrc.liv.ac.uk/orbit/ for a table 
generator) 
The number of outcomes should be determined by what is useful and interpretable. Given that the 
average number of outcomes in reviews was more than eight, which has been reported before [10], 
it is apparently difficult to restrict the number of outcomes. In line with the authors of the GRADE 
working group, we consider that restricting the number of outcomes would make reviews easier to 
read and better to understand. One potential way to do so would be to follow guidance by the 
‘Outcome Measures in Rheumatology’ group (OMERACT) which makes a distinction between 
outcome areas, outcome domains (equivalent to COMET’s ‘core outcome set’), and outcome 
measurements.[29] OMERACT distinguishes the following core areas of outcomes: death, life impact, 
resource use, and pathophysiological manifestations. The group advises that every trial at least 
includes one outcome domain under each of these core area headings but resource use is not 
mandatory. For each outcome domain there should be at least one valid outcome measurement 
defined. This would restrict the number of outcomes to three. It could then be acknowledged that 
the intervention could also be evaluated with other outcomes and that this could be the topic of 
another review. This is no different than restricting the number of interventions or the types of 
participants in a systematic review. Ultimately, a decision-maker wants to know what the most 
effective intervention is for a specific outcome of their interest. This will always require one or more 
overviews of reviews or network meta-analyses to determine this. 
Comparison with other studies 
Other studies that surveyed systematic reviews also concluded that there are issues with the 
outcomes. Smith et al and Aromataris et al concluded that authors of systematic reviews use too 
many outcomes.[10, 30]   Saldanha et al found that there is no consistent use of outcomes across 
reviews of various interventions for the same disease.[31] Chow et al studied preferences of patients 
for the use of cardiovascular disease outcomes in trials.[32] They found that patients had a 
preference for single outcomes such as stroke or coronary heart disease as opposed to more difficult 
to interpret composite outcomes such as cardiovascular disease. This indicates that there is a 
preference for more clarity as opposed to being exhaustive. This supports our conclusion that 
systematic reviews should include fewer outcomes. 
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Recently, Clarke et al recommended the use of core outcome sets in systematic reviews.[33] Even 
though in general core outcome sets are considered important by Cochrane review group 
coordinating editors [34], we did not see core outcome sets used in the reviews included in this 
survey. We checked if the topics of the included reviews were covered in the COMET database 
(http://www.comet-initiative.org). Of the topics of the included reviews, 67% was covered in the 
database but many records only indicated that research was ongoing (no core outcome sets agreed 
yet). Still, according to our assessment, for 38% of the reviews a published core outcome set could 
have been included. Two previous surveys of outcome reporting in Cochrane reviews also did not 
find a description of core outcome sets in any of the reviews published in 2007, 2011, and 2013.[10, 
11] It could be that in some cases these were used but that the authors did not describe them as 
such. We also discussed with some co-ordinating editors within Cochrane. It may be that there is a 
long history of using relevant outcomes within a review group already before COS were developed 
and that review groups feel no need to check this within the COS database. It is certainly an issue 
that warrants further exploration. To enable more prevalent use of core outcome sets in reviews, 
Cochrane review groups could list the available core outcomes sets applicable to their fields in 
author resources sections or request that reviews state clearly if they have used these sets.  
Implications for practice 
Authors of systematic reviews should explain in more detail if and how they used outcomes for 
inclusion of studies because this is not self-evident. The number of outcomes in a review should be 
reduced as this will improve the readability and the understanding of the findings of a review. 
Review authors should make a distinction between outcome as a concept (the ‘what’) and as its 
measurements (the ‘how’). In cases where studies are not sufficiently defined by the participants 
and intervention, the inclusion of studies should also be based on outcome concepts but not on 
outcome measures. 
Implications for research  
There is a need for consensus development work on the names and definition of outcome types and 
their use in Cochrane systematic reviews, including across guidance sources. Clearer distinction 
between primary and secondary outcomes is also needed for review authors. 
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